Purpose: To address the controversial issue of whether the occurrence of corneal hydrops adversely affects the fate of subsequent penetrating keratoplasty (PK), this study compared the longterm outcomes of PK in keratoconic eyes with resolved corneal hydrops with those without prior corneal hydrops.
A cute corneal hydrops develops when sudden spontaneous rupture of the Descemet membrane (DM) leads to bullous corneal edema, in eyes with progressive keratectasia. 1 It is a rare complication of keratoconus affecting only 2% to 3% of cases and is associated with severe ocular allergy. 2, 3 Resolution is spontaneous and 31% to 63% of patients recover useful vision with contact lenses. 2, 3 However, poor vision because of central corneal scarring or contact lens intolerance necessitates a penetrating keratoplasty (PK) in 20% to 59% of patients. [2] [3] [4] Among the numerous studies that have reported the long-term outcomes of PK in keratoconus, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] only two previous studies have explored the association between corneal hydrops and allograft rejection/survival but with conflicting results. 3, 4 Although Tuft et al 3 noted that eyes with resolved hydrops had significantly higher chances of endothelial rejection episodes compared with those without hydrops (20% vs. 5%; P = 0.02), Akova et al 4 noted fewer allograft rejection episodes in the hydrops group (6% vs. 11%; P = 0.7). Tuft et al 3 postulated that rejection episodes may be more common after hydrops because of the associated ocular allergy and/or vascularization; however, this association was not tested statistically. To address this controversial issue, in this large case series, we compared the long-term clinical outcomes of PK in keratoconic eyes with resolved corneal hydrops with those without prior corneal hydrops.
METHODS

Patient Selection
This study followed the tenets of the Declaration of Helsinki and was approved by the Ethics Committee of the L V Prasad Eye Institute, Hyderabad, India. This was a retrospective interventional study of patients with clinically diagnosed keratoconus who underwent corneal transplantation between January 1995 and December 2009. Exclusion criteria were cases in which (1) the treatment and/or duration of corneal hydrops could not be reliably ascertained, (2) lamellar keratoplasty was performed, (3) PK was performed for nonoptical indications, (4) PK was performed before complete clinical resolution of corneal hydrops, and (5) post-PK follow-up was less than 1 year.
Data Collection
All patients underwent a comprehensive ophthalmic examination at each follow-up visit. The medical records of the eligible patients were reviewed by 1 examiner (S.B.), and the relevant demographic and clinical data were collected in predesigned spreadsheets. Acute corneal hydrops was defined clinically as sudden onset of bullous corneal edema in eyes with keratoconus with or without an identifiable break in the DM on slit-lamp examination. Duration of corneal hydrops was calculated from the date of onset of symptoms to the date of complete disappearance of corneal edema on slit-lamp examination. Associated ocular allergy was diagnosed based on symptoms of itching and/or eye rubbing along with clinical signs of papillary reaction on the tarsal and/or limbal conjunctiva. An endothelial rejection episode was defined clinically as the acute onset of anterior uveitis with keratic precipitates on the graft endothelium and overlying graft edema.
Interventions
During acute corneal hydrops, all patients received tapering doses of topical steroid (prednisolone acetate 1%), lubricant (carboxymethyl cellulose sodium 0.5%), hyperosmotic (sodium chloride 5%), and cycloplegic (homatropine hydrobromide 2%) eye drops until the clinical resolution of corneal edema. Some patients also received a single intracameral injection of 14% perfluoropropane (C 3 F 8 ) gas. 2 A standard PK procedure was performed for all patients, under local or general anesthesia, using donor corneas stored in McCarey Kaufman medium, with a 0.25 to 0.5 mm over sizing of the donor corneal button and 10-0 nylon interrupted suturing. All patients were seen again on day 1, day 7, and day 30 postoperatively. Subsequent follow-up and selective suture removal were performed according to the discretion of the treating ophthalmologist. All patients received topical steroid (prednisolone acetate 1%) and antibiotic (ciprofloxacin 0.3%) eye drops for 1 week postoperatively after which the antibiotic was discontinued and the steroids were tapered gradually. After the initial 3 to 6 months, most patients were maintained on a once daily or twice daily dosing of steroid eye drops. In the event of an endothelial rejection episode, the topical steroid dosage was intensified, starting from every 1 hourly, and tapered according to the response. Systemic steroids were not administered for endothelial rejection episodes.
Histopathology Findings
The corneal buttons of all 102 cases were retrieved from the Ophthalmic Pathology Laboratory. The hematoxylin and eosin and periodic acid-Schiff-stained sections of formalin-fixed paraffin-embedded tissues were reviewed by 2 observers (G.K.V. and S.B.) and evaluated with special attention to the appearance of DM and endothelium.
Outcome Measure
The primary outcome measure was endothelial rejectionfree allograft survival. The survival time was calculated in months from the date of PK to the date the patient developed the first episode of endothelial rejection or failure (clinically defined as the loss of transparency of the central cornea for at least 3 months). The secondary outcome measure was bestcorrected visual acuity (BCVA), assessed at 6 time points: yearly from 1 to 5 years and 10 years postoperatively. All other postoperative complications after PK were also noted.
Statistical Analysis
All statistical analysis was performed using MedCalc version 11.3 for Windows (MedCalc Software, Mariakerke, Belgium). Means with SDs were reported for all normally distributed continuous variables. Preoperative features, postoperative vision, and complications were compared using the x 2 test (Yates corrected). Kaplan-Meier survival analysis was performed to estimate the cumulative probability (reported as percentage with standard error) of endothelial rejection-free allograft survival. Univariate (log rank test) analysis was done to identify the variables associated with allograft survival, which were subsequently fitted in a multivariate (Cox proportional hazard) model to estimate their relative effect on allograft survival (after checking all the assumptions and interactions of the model). A P value of less than 0.05 was considered to be statistically significant.
RESULTS
Demographic and Baseline Data
Of the 442 eyes of 398 patients who underwent corneal transplantation for keratoconus in the study period, 102 eyes of 102 patients were included in the study (255 eyes with inadequate post-PK follow-up, 66 eyes undergoing anterior lamellar keratoplasty, 12 eyes treated elsewhere for hydrops, 5 eyes operated before resolution of hydrops, and 2 eyes undergoing therapeutic PK were excluded). The age of the patients at PK was 20.4 ± 9.5 years. In the 32 patients with corneal hydrops, the age at acute hydrops was 19.6 ± 9.3 years, duration of corneal hydrops was 4.3 ±2.6 months (2.25 ± 1.5 months in 8 C 3 F 8 -treated eyes and 4.1 ± 1.6 months in other 24 eyes), and the duration between resolution of hydrops and PK was 11.2 ± 7.2 months. Table 1 shows that at the time of PK, eyes with hydrops had a significantly higher association with ocular allergy than others (P , 0.0001).
Primary Outcome
The Kaplan-Meier endothelial rejection-free allograft survival rates were 98% ± 1% at 1 year, 92.9% ± 3% at 5 years, and 87.3% ± 5% at 10 years (Fig. 1A) . The endothelial rejection-free allograft survival rates at 1, 5, and 10 years postoperatively were 93.7% ± 4% and 82.6% ± 7%, respectively, in 32 eyes with hydrops and 100%, 98% ± 2%, and 90.1% ± 6%, respectively, in 70 eyes without hydrops (P = 0.04; Fig. 1B ). An endothelial rejection episode occurred in 7 eyes (6.8%), all of which were reversed with intensive topical medication. None of the eyes had epithelial or stromal rejection episodes. Allograft failure occurred in 1 eye after acute postoperative endophthalmitis with graft melting. On univariate analysis, occurrence of hydrops, duration of hydrops (.3 months), coexistent ocular allergy, and corneal vascularization were found to be significantly associated with endothelial rejection-free allograft survival ( Table 2) . Multivariate analysis showed a significantly higher risk of endothelial rejection episodes in eyes with longer duration of corneal hydrops (hazard ratio, 6.1; 95% confidence intervals, 1.4-27.4; P = 0.019) and coexistent ocular allergy (hazard ratio 8.5; 95% confidence intervals, 1.6-45.3; P = 0.012).
Secondary Outcome
The visual outcomes after PK are provided in Table 3 . At all follow-up visits, more than 90% of patients had BCVA of better than 20/40. Astigmatism was 4.3 ± 2.6 diopters (D), 3.4 ± 1.6 D, 3 ± 1.2 D, 2.8 ± 1.2 D, 2.6 ± 0.9 D, and 2.3 ± 0.8 D at 1 years and 2, 3, 4, 5, and 10 years, respectively. Corneal topography-guided selective removal of tight sutures was successful in treating patients with high postoperative astigmatism, and no patients developed keratectasia or needed additional surgical interventions.
Complications
One patient presented with acute postoperative endophthalmitis with graft infiltrate and melting, 5 days after PK. Immediate therapeutic PK with pars plana vitrectomy were performed along with intraocular injection of 0.1 mL each of ceftazidime (2.25 mg) and vancomycin (1 g). The vitreous on culture showed significant growth of Streptococcus pneumoniae. One year postoperatively, the patient had a clear graft with BCVA of 20/40. Loose sutures were seen in 16 eyes (15.7%), all within 12 months of PK. Five of these eyes (4.9%) developed peripheral graft infiltrates caused by coagulase-negative Staphylococcus species. Complete resolution of infection and scarring was seen in all 5 eyes with intensive application of fortified cefazolin (5%) eye drops. Visually significant posterior subcapsular cataract developed in 7 eyes (6.8%), and all patients underwent uneventful phacoemulsification with posterior chamber intraocular lens implantation. None of the 102 eyes showed an increase in intraocular pressure or needed antiglaucoma medications during the entire study period.
Histopathology Findings
All specimens showed epithelial hyperplasia, fragmentation of the Bowman layer with variable scarring, and thinning of the corneal stroma; these features were consistent with a clinical diagnosis of keratoconus. DM and endothelium were normal in eyes without a clinical diagnosis of resolved hydrops. A single DM break was identified in all 32 specimens with resolved hydrops, but interestingly, the appearance of DM was different in cases that had received C 3 F 8 from the ones that had not. In post-C 3 F 8 cases, the broken ends of DM were rolled or folded at one end and flat at the other end, both ends being attached to or buried in the posterior corneal stroma (Fig. 2) . In non-C 3 F 8 -treated cases, 2 patterns were seen: (1) detachment of one end of DM, whereas the other end was seen lying rolled or flat against the posterior stroma ( Fig. 3A) or (2) rolling of both ends of DM with attachment to the posterior corneal stroma (Fig. 3B ). Interestingly, folding or burial of DM in the corneal stroma was a feature seen exclusively in 7 post-C 3 F 8 cases (87.5%), suggestive of the pressure tamponade by the gas bubble. All 32 cases showed endothelial cell migration between the 2 broken ends of DM and relayering of a thin periodic acid-Schiff-positive membrane, suggestive of the healing process after hydrops.
DISCUSSION
Keratoconus is a noninflammatory corneal pathology, which makes it immunologically ideal for a successful PK. Tuft et al 3 hypothesized that this immune privilege is compromised in eyes developing corneal hydrops because of the associated ocular allergy and peripheral corneal vascularization, leading to a greater risk of developing allograft rejection episodes after PK. However, this hypothesis could not be validated in a subsequent study by Akova et al. 4 Our study aimed to reevaluate the controversial association between corneal hydrops and subsequent allograft rejection episodes and allograft survival. We found that keratoconic eyes with prolonged duration of corneal hydrops and/or coexistent ocular allergy were more prone to developing endothelial rejection episodes after PK. However, endothelial rejection episodes were rare, medically reversible, and did not lead to allograft failure. The visual outcomes of PK in eyes with keratoconus, irrespective of corneal hydrops, were excellent and stable throughout the duration of the study. Kaplan-Meier survival curves showing endothelial rejection-free graft survival in eyes undergoing PK for keratoconus. A, The survival rate for all 102 eyes was 98% ± 0.01% at 1 year, 92.9% ± 0.03% at 5 years, and 87.3% ± 0.05% at 10 years. B, Comparison between 32 eyes with hydrops and 70 eyes without hydrops showing that there was a significant difference in the endothelial rejection-free survival rate between these 2 groups (log rank test; P = 0.04). Although the reported incidence of endothelial rejection episodes after PK in keratoconus varies widely from 3.6% to 31%, allograft survival at 5 to 12 years has been consistently reported to be greater than 90%. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Occurrence of endothelial rejection episodes in our series (6.8%, 102 eyes; mean follow-up, 5.5 years) was similar to that noted by Lim et al 5 follow up, 2 years) noted a much higher rejection episode rate of 21% and 31%, respectively. Whether the proportion of cases with hydrops or ocular allergy was higher in the latter 2 studies is not known. Surprisingly, we did not note any cases with epithelial or stromal rejection episodes, which may have been inadvertently missed had they occurred between scheduled follow-up visits or before episodes of endothelial rejection.
Because ocular allergy is known to be associated with both corneal hydrops 2,3 and endothelial rejection episodes after PK, 19 it can potentially confound the association between the latter 2 variables. To address this issue, we performed a multivariate analysis, which revealed that both ocular allergy and duration of corneal hydrops were independent risk factors for the development of endothelial rejection episodes. However, all endothelial rejection episodes were reversed with appropriate medical therapy, and none of the eyes developed allograft failure after rejection. In fact, compared with endothelial rejection, nonimmunological causes account for a significant proportion of allograft failures (42.8%-100%) seen after PK in keratoconus. [3] [4] [5] [6] [7] [8] [9] [10] The histopathology of corneas with resolved hydrops has been described earlier. 20, 21 However, to our knowledge, this is the first study to report the histopathology of resolved hydrops after intracameral gas injections. The unique findings in post-C 3 F 8 corneas were greater attachment of DM to the posterior stroma and burial of the rolled or folded DM in the stroma, both of which seem to be compression effects of the gas bubble on the DM. Separation between the split ends of DM shows that despite C 3 F 8 , end-to-end reapproximation of the DM was not possible because of the elastic coiling and retraction of DM after rupture. There are concerns about the safety of intracameral gases on the endothelium, 22, 23 but at least on histopathology, we did not find any signs of endothelial attenuation in eyes that received C 3 F 8 .
Recently, 3 different surgical techniques of deep anterior lamellar keratoplasty (DALK) have been described for eyes with keratoconus and resolved corneal hydrops. [24] [25] [26] Interestingly, the authors cited an increased risk of allograft rejection/ failure as the main reason for choosing DALK over PK. [24] [25] [26] However, performing DALK in eyes with resolved hydrops is technically challenging. As shown by our histopathologic data, the area of the DM break is lined by an extremely thin basement membrane, which is likely to give way easily, especially if a big-bubble is attempted. Leaving behind a sliver of the posterior stroma, as described by Das et al 24 and Chew et al, 25 may be advisable to prevent an inadvertent perforation. Early suture removal and discontinuation of topical steroids after DALK can help in avoiding loose suture-related graft infiltrates and steroid-induced cataracts, which were the most common complications after PK in this study. The limitations of this study are inherent to its retrospective design. In our previous study, we found that acute corneal hydrops occurs in 3% of eyes with keratoconus, of which only 20% require PK for visual rehabilitation. 2 In view of the rarity of acute corneal hydrops, the infrequent need for PK in resolved corneal hydrops, and the low rate of allograft rejection/failure in keratoconus, a retrospective approach was considered appropriate. Multiple surgeons were involved in this study, and it does not include long-term data on endothelial cell count, morphology, or corneal topography.
In conclusion, we studied the long-term endothelial rejection-free allograft survival after PK in eyes with keratoconus. We found that despite higher chances of endothelial rejection episodes in eyes with prior corneal hydrops, especially those with active ocular allergy and longer duration of hydrops, allograft failure was rare and the visual outcomes of PK in the long run were excellent. Patients at a higher risk for endothelial rejection episodes must be educated about its symptoms and about the importance of early reporting to the ophthalmologist once the symptoms develop. Although we cannot prevent endothelial rejection episodes, allograft failure because of rejection can certainly be successfully treated. FIGURE 3 . Photomicrographs of periodic acid-Schiff-stained sections of corneal buttons obtained during PK. A, Corneal specimen from case 29 showing a break in the DM (black arrows, ·20), one end of which is partially detached from the stroma with endothelium on both sides, whereas the other end is rolled and attached to the stroma. B, Specimen from case 31 showing a break in the DM with rolling of both ends (black arrows, ·20). These 2 patterns were seen in cases that did not receive intracameral gas.
